We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment and Complication of Bath PUVA in Vitiligo

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2008 by Shahid Beheshti University of Medical Sciences.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00380471
First Posted: September 26, 2006
Last Update Posted: January 23, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Shahid Beheshti University of Medical Sciences
  Purpose
The purpose of this study is to determine whether bath PUVA are effective in treatment of vitiligo and what is the complication of bath PUVA in vitiligo.

Condition Intervention Phase
Vitiligo Device: Bath PUVA Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Treatment and Complication of Bath PUVA in Vitiligo

Resource links provided by NLM:

MedlinePlus related topics: Vitiligo
U.S. FDA Resources

Further study details as provided by Shahid Beheshti University of Medical Sciences:
Study Start Date: January 2006
Estimated Study Completion Date: August 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Vitiligo

Exclusion Criteria:

  • Pregnancy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00380471


Contacts
Contact: Parviz Toossi, M.D. 98-21-22744392 ext 5 src@sbmu.ac.ir

Locations
Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University Recruiting
Tehran, Iran, Islamic Republic of, 19899
Contact: Parviz Toossi, M.D.    98-21-22744392    src@sbmu.ac.ir   
Principal Investigator: Parviz Toossi, M.D.         
Sub-Investigator: Fatemeh Aryanejad, MD         
Sub-Investigator: Gita Meshkat Razavi, MD         
Sponsors and Collaborators
Shahid Beheshti University of Medical Sciences
Investigators
Study Chair: Parviz Toossi, M.D. Shahid Beheshti University of Medical Sciences
  More Information

ClinicalTrials.gov Identifier: NCT00380471     History of Changes
Other Study ID Numbers: src-pts-968
First Submitted: September 25, 2006
First Posted: September 26, 2006
Last Update Posted: January 23, 2008
Last Verified: January 2008

Keywords provided by Shahid Beheshti University of Medical Sciences:
bath PUVA

Additional relevant MeSH terms:
Vitiligo
Hypopigmentation
Pigmentation Disorders
Skin Diseases